Apple’s Health app can now tell you if you’re in perimenopause
Cycle tracker will now notify women when their cycle patterns are suggestive of perimenopause.
Cycle tracker will now notify women when their cycle patterns are suggestive of perimenopause. This report comes from TechCrunch. The story centres o
Read Full Story at TechCrunch →Why This Matters
Apple’s expansion of its Health app into perimenopause tracking marks a quiet but pivotal step in normalizing women’s health data collection. By integrating cycle irregularity alerts into a mainstream platform, it not only destigmatizes a natural life stage but also empowers users with actionable insights—potentially bridging gaps in medical awareness that have historically left women navigating perimenopause symptoms without clear guidance or diagnosis.
Background Context
Perimenopause, the 3-to-10-year transition to menopause, has long been understudied and poorly understood, with symptoms often dismissed as stress or aging. Medical research has historically prioritized male health or post-menopausal care, leaving a void in tools tailored to the 40+ demographic navigating hormonal shifts. Meanwhile, Apple’s Health app has quietly evolved from a fitness tracker into a repository for sensitive reproductive data, raising questions about privacy and the role of tech in healthcare.
What Happens Next
This feature could pressure healthcare systems to better integrate digital biomarkers into clinical workflows, forcing insurers and providers to adapt. It may also intensify debates over data ownership, as users entrust Apple with intimate health patterns that could be leveraged for research—or exploited by advertisers. Competitors like Google and Fitbit are likely to follow, turning perimenopause tracking into a new battleground for consumer health tech dominance.
Bigger Picture
This move aligns with a broader trend of tech platforms encroaching on traditional medical domains, from glucose monitoring to mental health. It reflects a growing demand for personalized health tools, but also a reliance on proprietary algorithms to interpret biological data. As fertility and aging become focal points for innovation, the line between preventive care and commercial data harvesting will only blur further.
